R&D
Elix and University of Vienna Team Up to Aim AI at ‘Undruggable’ Shape-Shifting Proteins
The Tokyo AI firm and Julien Orts’s NMR lab will combine machine learning with atomic-resolution spectroscopy to target intrinsically disordered proteins in cancer.